• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

社交媒体平台作为幽门螺杆菌治疗中患者提醒的应用。

Application of a social media platform as a patient reminder in the treatment of Helicobacter pylori.

机构信息

Department of Gastroenterology, The First Affiliated Hospital, Shihezi University School of Medicine, Xinjiang, China.

Department of Urology, The First Affiliated Hospital, Shihezi University School of Medicine, Xinjiang, China.

出版信息

Helicobacter. 2020 Apr;25(2):e12682. doi: 10.1111/hel.12682. Epub 2020 Feb 23.

DOI:10.1111/hel.12682
PMID:32088934
Abstract

BACKGROUND

To investigate the effect of a social media platform for the treatment of Helicobacter pylori infection.

MATERIALS AND METHODS

We enrolled 222 patients from October 2018 to June 2019, who required H pylori therapy. We used WeChat, a social media platform, as a patient reminder tool. They were randomly divided into the intervention and control groups (n = 111 per group) to compare and evaluate their disease awareness, medication adherence, incidence of adverse drug reactions, and H pylori eradication rate.

RESULTS

Patients in the intervention group had significantly better disease-related knowledge, medication adherence, and H pylori eradication rates than those in the control group (P < .05).

CONCLUSIONS

Using a social media platform may improve treatment rates of H pylori infection.

摘要

背景

研究社交媒体平台在治疗幽门螺杆菌感染中的作用。

材料与方法

我们于 2018 年 10 月至 2019 年 6 月招募了 222 名需要接受幽门螺杆菌治疗的患者。我们使用社交媒体平台微信作为患者提醒工具。将他们随机分为干预组和对照组(每组 111 例),以比较和评估他们的疾病意识、用药依从性、药物不良反应发生率和幽门螺杆菌根除率。

结果

干预组患者在疾病相关知识、用药依从性和幽门螺杆菌根除率方面明显优于对照组(P<0.05)。

结论

使用社交媒体平台可能会提高幽门螺杆菌感染的治疗率。

相似文献

1
Application of a social media platform as a patient reminder in the treatment of Helicobacter pylori.社交媒体平台作为幽门螺杆菌治疗中患者提醒的应用。
Helicobacter. 2020 Apr;25(2):e12682. doi: 10.1111/hel.12682. Epub 2020 Feb 23.
2
Application of WeChat platform in the management of patients infected with Helicobacter pylori.微信平台在幽门螺杆菌感染患者管理中的应用。
Helicobacter. 2021 Oct;26(5):e12832. doi: 10.1111/hel.12832. Epub 2021 Jul 7.
3
Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease.基于莫西沙星的序贯疗法对胃肠道疾病中幽门螺杆菌感染一线根除的疗效
World J Gastroenterol. 2015 Apr 28;21(16):5032-8. doi: 10.3748/wjg.v21.i16.5032.
4
Efficacy of 14-d vs 7-d moxifloxacin-based triple regimens for second-line Helicobacter pylori eradication.基于莫西沙星的14天与7天三联疗法用于二线根除幽门螺杆菌的疗效
World J Gastroenterol. 2015 May 14;21(18):5568-74. doi: 10.3748/wjg.v21.i18.5568.
5
Fourteen- vs seven-day bismuth-based quadruple therapy for second-line Helicobacter pylori eradication.用于二线根除幽门螺杆菌的铋剂四联疗法:十四天与七天对比
World J Gastroenterol. 2015 Jul 14;21(26):8132-9. doi: 10.3748/wjg.v21.i26.8132.
6
Outcomes of furazolidone- and amoxicillin-based quadruple therapy for infection and predictors of failed eradication.呋喃唑酮和阿莫西林四联疗法治疗感染的结果及根除失败的预测因素。
World J Gastroenterol. 2018 Oct 28;24(40):4596-4605. doi: 10.3748/wjg.v24.i40.4596.
7
Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line Helicobacter pylori eradication.基于莫西沙星的序贯和联合疗法用于一线根除幽门螺杆菌的疗效
World J Gastroenterol. 2015 Sep 21;21(35):10234-41. doi: 10.3748/wjg.v21.i35.10234.
8
Randomized Clinical Trial: Esomeprazole, Bismuth, Levofloxacin, and Amoxicillin or Cefuroxime as First-Line Eradication Regimens for Helicobacter pylori Infection.随机临床试验:埃索美拉唑、铋剂、左氧氟沙星和阿莫西林或头孢呋辛作为幽门螺杆菌感染的一线根除方案
Dig Dis Sci. 2017 Jun;62(6):1580-1589. doi: 10.1007/s10620-017-4564-4. Epub 2017 Apr 8.
9
Seven-day quintuple regimen as a rescue therapy for Helicobacter pylori eradication.七日五联疗法作为幽门螺杆菌根除的挽救治疗方法。
World J Gastroenterol. 2015 Jan 14;21(2):661-6. doi: 10.3748/wjg.v21.i2.661.
10
[The Efficacy of Bismuth-containing Quadruple Therapy after Moxifloxacin-based Sequential Therapy Failure in Helicobacter pylori Eradication].[莫西沙星序贯治疗失败后含铋剂四联疗法根除幽门螺杆菌的疗效]
Korean J Gastroenterol. 2018 Apr 25;71(4):196-203. doi: 10.4166/kjg.2018.71.4.196.

引用本文的文献

1
Comparative evaluation of the accuracy and reliability of ChatGPT versions in providing information on infection.ChatGPT不同版本在提供感染相关信息方面的准确性和可靠性的比较评估
Front Public Health. 2025 May 15;13:1566982. doi: 10.3389/fpubh.2025.1566982. eCollection 2025.
2
Knowledge, attitude, and practice toward Helicobacter pylori among residents in Northeast China‌.中国东北地区居民对幽门螺杆菌的认知、态度及行为
Sci Rep. 2025 May 1;15(1):15288. doi: 10.1038/s41598-025-00323-9.
3
Care-Seeking Action after Helicobacter pylori Testing among a High-Risk Indigenous Population: A Cross-Sectional Study Follow-up.
高危原住民人群幽门螺杆菌检测后的就医行为:一项横断面研究随访
Am J Trop Med Hyg. 2024 Dec 24;112(3):518-524. doi: 10.4269/ajtmh.24-0393. Print 2025 Mar 5.
4
Current paradigms in the management of refractory Helicobacter pylori infection.难治性幽门螺杆菌感染的当前管理范式。
Indian J Gastroenterol. 2023 Dec;42(6):766-779. doi: 10.1007/s12664-023-01448-3. Epub 2023 Sep 22.
5
A day-to-day management model improves patient compliance to treatment for Helicobacter pylori infection: a prospective, randomized controlled study.日常管理模式可提高幽门螺杆菌感染患者的治疗依从性:一项前瞻性随机对照研究。
Gut Pathog. 2023 Jul 31;15(1):38. doi: 10.1186/s13099-023-00556-x.
6
Rescue therapy for refractory infection: current status and future concepts.难治性感染的挽救治疗:现状与未来概念
Therap Adv Gastroenterol. 2023 May 6;16:17562848231170941. doi: 10.1177/17562848231170941. eCollection 2023.
7
The management of infection and prevention and control of gastric cancer in China.中国胃癌感染的管理和防控。
Front Cell Infect Microbiol. 2022 Dec 1;12:1049279. doi: 10.3389/fcimb.2022.1049279. eCollection 2022.
8
Application of a WeChat-based mini-app as a patient reminder in Helicobacter pylori eradication: a prospective multi-center randomized controlled study.基于微信小程序的患者提醒在幽门螺杆菌根除中的应用:一项前瞻性多中心随机对照研究。
BMC Gastroenterol. 2022 Dec 16;22(1):520. doi: 10.1186/s12876-022-02614-1.
9
Current and Future Perspectives in the Diagnosis and Management of Infection.感染诊断与管理的现状及未来展望
J Clin Med. 2022 Aug 30;11(17):5086. doi: 10.3390/jcm11175086.
10
High-Dose Dual Therapy Versus Bismuth-Containing Quadruple Therapy for the Treatment of Helicobacter pylori Infection: A Systematic Review with Meta-Analysis.高剂量双联疗法与铋剂四联疗法治疗幽门螺杆菌感染的系统评价与 Meta 分析。
Turk J Gastroenterol. 2022 Jun;33(6):454-462. doi: 10.5152/tjg.2022.21579.